✦ LIBER ✦

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

✍ Scribed by Middleton, Gary; Silcocks, Paul; Cox, Trevor; Valle, Juan; Wadsley, Jonathan; Propper, David; Coxon, Fareeda; Ross, Paul; Madhusudan, Srinivasan; Roques, Tom; Cunningham, David; Falk, Stephen; Wadd, Nick; Harrison, Mark; Corrie, Pippa; Iveson, Tim; Robinson, Angus; McAdam, Karen; Eatock, Martin; Evans, Jeff; Archer, Caroline; Hickish, Tamas; Garcia-Alonso, Angel; Nicolson, Marianne; Steward, William; Anthoney, Alan; Greenhalf, William; Shaw, Victoria; Costello, Eithne; Naisbitt, Dean; Rawcliffe, Charlotte; Nanson, Gemma; Neoptolemos, John

Book ID: 125794155
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 385 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70236-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and cisplatin with or witho

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

✍ Lordick, Florian; Kang, Yoon-Koo; Chung, Hyun-Cheol; Salman, Pamela; Oh, Sang Ch 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 323 KB

Epirubicin, oxaliplatin, and capecitabin

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

✍ Waddell, Tom; Chau, Ian; Cunningham, David; Gonzalez, David; Okines, Alicia Fran 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 396 KB

Cisplatin and fluorouracil with or witho

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

✍ Vermorken, Jan B; Stöhlmacher-Williams, Jan; Davidenko, Irina; Licitra, Lisa; Wi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 615 KB

Oxaliplatin, fluorouracil, and leucovori

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

✍ Taieb, Julien; Tabernero, Josep; Mini, Enrico; Subtil, Fabien; Folprecht, Gunnar 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 466 KB

Quality of life in patients with locally

Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial

✍ Per Fransson; Jo-Åsmund Lund; Jan-Erik Damber; Olbjörn Klepp; Fredrik Wiklund; S 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 184 KB

Concomitant chemoradiotherapy versus acc

Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial

✍ Jean Bourhis; Christian Sire; Pierre Graff; Vincent Grégoire; Philippe Maingon; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 332 KB